Clinical trial
Investigation of a New, Oral Growth Hormone Secretagogue, AEZS-130 as a Growth…
NCT00448747 · AEterna Zentaris, Industry · Completed
Key facts
| NCT number | NCT00448747 |
|---|---|
| Title | Investigation of a New, Oral Growth Hormone Secretagogue, AEZS-130 as a Growth Hormone Stimulation Test. |
| Official title | A Multi-center, Study Investigating a New, Oral Growth Hormone Secretagogue (GHS)(AEZS 130, Formerly Ardana (ARD)-07) as a Growth Hormone (GH) Stimulation Test in Terms of Safety and Efficacy |
| Lead sponsor | AEterna Zentaris, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diagnosis of Adult Growth Hormone Deficiency (AGDH) |
| Intervention type | Drug |
| Interventions | AEZS-130 (formerly ARD-07), L-ARG+GHRH |
| Enrollment | 101 |
| Start date | Jun 1, 2007 |
| Primary completion | Jul 1, 2011 |
| Completion | Jul 1, 2011 |
| First posted | Mar 19, 2007 |
| Last update posted | Jul 23, 2019 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: